Dermata Therapeutics, Inc. (DRMA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -2.48M | -1.33M | -1.8M | -2.69M | -1.93M | -2.91M | -3.42M | -2.13M | -2.7M | -1.15M | -1.77M | -1.84M | -1.65M | -1.83M | -2.56M | -1.84M | -2.61M | -1.8M | -2.21M | -903.21K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -28.21% | 54.38% | 47.24% | -26.55% | 28.49% | -153.95% | -92.98% | -15.52% | -63.94% | 37.15% | 30.83% | -0.05% | 36.74% | -1.2% | -15.89% | -103.66% | -235.97% | -236.57% | - | - |
| Net Income | -1.85M | -1.86M | -1.69M | -1.7M | -2.3M | -3.15M | -3.17M | -2.83M | -3.13M | -2.13M | -1.72M | -1.7M | -2.24M | -1.67M | -2.42M | -2.73M | -2.79M | -2.55M | -1.71M | -1.33M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 37.84K | 39.23K | 37.19K | 29.82K | 20.99K | 19.61K | 587.23K | 128.47K | 131.18K | 131.18K | 131.26K | 220.89K | 234.98K | 261.57K | 212.88K | 488.72K | 142.66K | 113.99K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 43.28K | 29.47K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 156 | 78 |
| Working Capital Changes | -675.29K | 503.22K | -149.67K | -1.03M | 332.33K | 207.51K | -266.76K | 683.54K | -157.43K | 858.2K | -183.59K | -270.18K | 459.25K | -376.82K | -371.67K | 629.49K | -34.58K | 260.23K | -639.94K | 314.51K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -93.09K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -51.13K | -83.97K | 52.73K | -458.88K | 102.06K | -98.19K | -370.58K | 403.74K | -43.48K | 391.57K | 36.68K | -55.09K | -3.83K | 12.96K | 0 | -53.42K | 146.99K | -254.62K | -111.44K | 393.21K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 1.9M | 4.19M | -12.99K | -547.86K | 8.49M | -68.57K | 4.62M | 2.34M | 0 | 1.95M | -35.42K | 1.51M | 4.18M | 0 | 200 | 4.28M | 0 | -626 | 14.39M | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 1.9M | 4.19M | -12.99K | -547.86K | 8.49M | -69.51K | 4.55M | 2.41M | 0 | 1.95M | -35.42K | 1.51M | 4.17M | 0 | 200 | 4.28M | 0 | -626 | 14.39M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -367 | 0 | 0 | 0 | 828 | -828 | 0 | 0 | -35 | 0 | -40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 941 | 70.17K | -70K | 0 | 0 | 0 | 34 | 193 | 0 | 0 | 87 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -576.7K | 2.86M | -1.82M | -3.24M | 6.56M | -2.98M | 1.2M | 213.42K | -2.7M | 806.65K | -1.81M | -328.23K | 2.53M | -1.83M | -2.56M | 2.44M | -2.61M | -1.8M | 12.18M | -903.21K |
| Free Cash Flow | -2.48M | -1.33M | -1.8M | -2.69M | -1.93M | -2.91M | -3.42M | -2.13M | -2.7M | -1.15M | -1.77M | -1.84M | -1.65M | -1.83M | -2.56M | -1.84M | -2.61M | -1.8M | -2.21M | -903.21K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -28.21% | 54.38% | 47.24% | -26.55% | 28.49% | -153.95% | -92.98% | -15.52% | -63.94% | 37.15% | 30.83% | -0.05% | 36.74% | -1.2% | -15.89% | -103.66% | -235.97% | -236.57% | - | - |
| FCF per Share | -0.64 | -1.09 | -1.76 | -2.62 | -3.75 | -18.74 | -21.99 | -31.42 | -60.90 | -2.92 | -83.33 | -102.05 | -251.00 | -23.70 | -500.72 | -394.36 | -49.96 | -2.16 | -71.00 | -19.23 |
| FCF Conversion (FCF/Net Income) | 1.34x | 0.71x | 1.07x | 1.58x | 0.84x | 0.92x | 1.08x | 0.75x | 0.86x | 0.54x | 1.03x | 1.08x | 0.74x | 1.09x | 1.06x | 0.67x | 0.94x | 0.71x | 1.29x | 0.68x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 947 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 150 | 0 | 800 | 0 | 0 | 0 | 450 |